Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate.

Literature DB >> 8787923

Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate.

M Fujiwara¹, K Ijichi, K Tokuhisa, K Katsuura, S Shigeta, K Konno, G Y Wang, D Uemura, T Yokota, M Baba.

Abstract

Ingenol 3,5,20-triacetate (ITA), one of the ingenol derivatives, is a selective inhibitor of human immunodeficiency virus (HIV) replication in vitro. ITA inhibited the replication of HIV strains in MT-4 cells at concentrations of 0.051 to 0.65 microM. This concentration was approximately 10(3)-fold lower than its cytotoxic threshold. The mechanism of action of ITA is primarily attributed to the inhibition of viral adsorption to the host cells, but it is distinct from the mechanism of inhibition by other adsorption inhibitors.

Entities: Chemical Species

Mesh：

Substances：

Year: 1996 PMID： 8787923 PMCID： PMC163100

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

17 in total

1. A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.

Authors: K R Gustafson; J H Cardellina; J B McMahon; R J Gulakowski; J Ishitoya; Z Szallasi; N E Lewin; P M Blumberg; O S Weislow; J A Beutler
Journal: J Med Chem Date: 1992-05-29 Impact factor: 7.446

2. Specific binding to protein kinase C by ingenol and its induction of biological responses.

Authors: C M Hasler; G Acs; P M Blumberg
Journal: Cancer Res Date: 1992-01-01 Impact factor: 12.701

3. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.

Authors: M Baba; D Schols; R Pauwels; H Nakashima; E De Clercq
Journal: J Acquir Immune Defic Syndr (1988) Date: 1990

4. Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.

Authors: M Baba; E De Clercq; H Tanaka; M Ubasawa; H Takashima; K Sekiya; I Nitta; K Umezu; H Nakashima; S Mori
Journal: Proc Natl Acad Sci U S A Date: 1991-03-15 Impact factor: 11.205

5. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Authors: R Pauwels; K Andries; Z Debyser; P Van Daele; D Schols; P Stoffels; K De Vreese; R Woestenborghs; A M Vandamme; C G Janssen
Journal: Proc Natl Acad Sci U S A Date: 1993-03-01 Impact factor: 11.205

6. Stimulatory effects of ingenols from Euphorbia kansui on the expression of macrophage Fc receptor.

Authors: T Matsumoto; J C Cyong; H Yamada
Journal: Planta Med Date: 1992-06 Impact factor: 3.352

7. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.

Authors: M Baba; S Shigeta; S Yuasa; H Takashima; K Sekiya; M Ubasawa; H Tanaka; T Miyasaka; R T Walker; E De Clercq
Journal: Antimicrob Agents Chemother Date: 1994-04 Impact factor: 5.191

8. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.

Authors: I H Chowdhury; Y Koyanagi; S Kobayashi; Y Hamamoto; H Yoshiyama; T Yoshida; N Yamamoto
Journal: Virology Date: 1990-05 Impact factor: 3.616

9. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.

Authors: C Callebaut; B Krust; E Jacotot; A G Hovanessian
Journal: Science Date: 1993-12-24 Impact factor: 47.728

10. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.

Authors: H Golding; J Manischewitz; L Vujcic; R Blumenthal; D S Dimitrov
Journal: J Virol Date: 1994-03 Impact factor: 5.103

13 in total

Review 1. Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products.

Authors: Zachary G Brill; Matthew L Condakes; Chi P Ting; Thomas J Maimone
Journal: Chem Rev Date: 2017-03-15 Impact factor: 60.622

2. Stelleralides A-C, novel potent anti-HIV daphnane-type diterpenoids from Stellera chamaejasme L.

Authors: Yoshihisa Asada; Aya Sukemori; Takashi Watanabe; Kuber J Malla; Takafumi Yoshikawa; Wei Li; Kazuo Koike; Chin-Ho Chen; Toshiyuki Akiyama; Keduo Qian; Kyoko Nakagawa-Goto; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal: Org Lett Date: 2011-05-11 Impact factor: 6.005

3. Oxidopyrylium [5+2] Cycloaddition Chemistry: Historical Perspective and Recent Advances (2008-2018).

Authors: Lauren P Bejcek; Ryan P Murelli
Journal: Tetrahedron Date: 2018-04-05 Impact factor: 2.457

4. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.

Authors: Guochun Jiang; Erica A Mendes; Philipp Kaiser; Sumathi Sankaran-Walters; Yuyang Tang; Mariana G Weber; Greg P Melcher; George R Thompson; Amilcar Tanuri; Luiz F Pianowski; Joseph K Wong; Satya Dandekar
Journal: AIDS Date: 2014-07-17 Impact factor: 4.177

5. Isolation, structure determination, and anti-HIV evaluation of tigliane-type diterpenes and biflavonoid from Stellera chamaejasme.

Authors: Yoshihisa Asada; Aya Sukemori; Takashi Watanabe; Kuber J Malla; Takafumi Yoshikawa; Wei Li; Xinzhu Kuang; Kazuo Koike; Chin-Ho Chen; Toshiyuki Akiyama; Keduo Qian; Kyoko Nakagawa-Goto; Susan L Morris-Natschke; Yan Lu; Kuo-Hsiung Lee
Journal: J Nat Prod Date: 2013-04-23 Impact factor: 4.050